Philip Morris International Inc. logo

Philip Morris International Inc. (PM)

Market Closed
4 Dec, 20:00
NYSE NYSE
$
148. 58
-3.13
-2.06%
$
243.59B Market Cap
18.34 P/E Ratio
0% Div Yield
8,562,091 Volume
6.08 Eps
$ 151.71
Previous Close
Day Range
146.35 151.71
Year Range
116.12 186.69
Want to track PM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 62 days
Philip Morris Raises Dividend: A Look at Its Growth Strategy

Philip Morris Raises Dividend: A Look at Its Growth Strategy

PM has raised its quarterly dividend by 8.9%, underscoring growth through smoke-free products, cost savings and strong brands.

Zacks | 2 months ago
Philip Morris International Inc. (PM) Presents At Barclays 18th Annual Global Consumer Staples Conference 2025 Transcript

Philip Morris International Inc. (PM) Presents At Barclays 18th Annual Global Consumer Staples Conference 2025 Transcript

Philip Morris International Inc. (NYSE:PM ) Barclays 18th Annual Global Consumer Staples Conference 2025 September 2, 2025 11:15 AM EDT Company Participants Jacek Olczak - CEO & Director Conference Call Participants Gaurav Jain - Barclays Bank PLC, Research Division Presentation Gaurav Jain Research Analyst Good morning, everyone. Thank you for being here.

Seekingalpha | 3 months ago
Philip Morris: Quality Growth And What To Look For Going Forward

Philip Morris: Quality Growth And What To Look For Going Forward

Philip Morris' Q2 Zyn volumes missed expectations in the US, but strong overall SFB growth reinforces my long-term buy thesis as the company pivots to smoke-free products. SFB now represents 23% of volumes and 43% of gross margin, with superior unit economics—each SFB unit is twice as profitable as combustibles. Key metrics to track: sustained positive volume growth, SFB gross margin share surpassing 50%, and maintaining strong SFB unit economics without margin sacrifice.

Seekingalpha | 3 months ago
Philip Morris Transformation Accelerates With IQOS and ZYN Growth

Philip Morris Transformation Accelerates With IQOS and ZYN Growth

PM's second-quarter results show smoke-free gains lifting revenues and profit, even as cigarette volumes continue to decline.

Zacks | 3 months ago
Philip Morris: Historically Low Dividend Yield Justifies A Sell

Philip Morris: Historically Low Dividend Yield Justifies A Sell

Philip Morris International's growth is driven by smoke-free products like IQOS and ZYN, with strong sales momentum post-Swedish Match acquisition. Despite robust operational performance and a raised outlook, the stock's valuation appears stretched with an EV/FCF of 31x and a historically low 3.1% dividend yield. Much of the recent growth seems to be already priced in, and further upside seems limited, making the risk/reward profile unattractive at current levels.

Seekingalpha | 3 months ago
Philip Morris (PM) Up 5% Since Last Earnings Report: Can It Continue?

Philip Morris (PM) Up 5% Since Last Earnings Report: Can It Continue?

Philip Morris (PM) reported earnings 30 days ago. What's next for the stock?

Zacks | 3 months ago
Philip Morris: Further Shareholder Returns Upcoming

Philip Morris: Further Shareholder Returns Upcoming

Philip Morris is the world's largest publicly traded 'sin' stock, valued at over $250 billion. The company has a strong track record of outperforming the market, driven by its shareholder return focus. Recent earnings suggest PM still has significant growth potential ahead.

Seekingalpha | 3 months ago
PM Stock Trades at Premium Value: Should You Buy, Hold or Sell?

PM Stock Trades at Premium Value: Should You Buy, Hold or Sell?

Philip Morris' smoke-free growth is strong, but cigarette declines and a premium valuation urge cautious investment moves.

Zacks | 3 months ago
Philip Morris Aims for $2B Cost Savings by 2026: How Close Is It?

Philip Morris Aims for $2B Cost Savings by 2026: How Close Is It?

PM has already captured $1.2 billion in savings by mid-2025, keeping it on track to hit its $2 billion cost-cutting target by 2026.

Zacks | 3 months ago
Philip Morris' ILUMA Rollout: Will It Power H2 Volume Growth? (Revised)

Philip Morris' ILUMA Rollout: Will It Power H2 Volume Growth? (Revised)

ILUMA's broader launch and expanded consumables range are contributing to PM's heated tobacco growth in 2025.

Zacks | 3 months ago
Philip Morris' ILUMA Rollout: Will It Power H2 Volume Growth?

Philip Morris' ILUMA Rollout: Will It Power H2 Volume Growth?

ILUMA's broader launch and expanded consumables range are contributing to PM's heated tobacco growth in 2025.

Zacks | 3 months ago
Night Watch Investment Management Q2 2025 Position Updates

Night Watch Investment Management Q2 2025 Position Updates

Haypp remains our largest position, offering rapid growth, a defensible moat, and high-margin insights business in the booming nicotine pouch market. X-FAB is attractively valued with two near-term catalysts: capacity expansion and a new dividend, plus strong insider ownership and overlooked profit growth. We exited Dream International after a 160% return, as the stock is no longer cheap post-Labubu news and lacks a clear catalyst for further upside.

Seekingalpha | 4 months ago
Loading...
Load More